Featured Research

from universities, journals, and other organizations

Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy

Date:
October 7, 1998
Source:
Thomas Jefferson University
Summary:
Scientists at Jefferson Medical College believe they have taken the next step toward gene therapy trials for lung cancer.

Scientists at Jefferson Medical College believe they have taken the next step toward gene therapy trials for lung cancer.

They have demonstrated for the first time in laboratory animals that a normally protective anticancer gene, pRb2/p130, can actually block tumors from growing. A damaged version of the gene, termed a "tumor suppressor," has been implicated in several cancers, such as lung, breast and endometrial.

Previous test tube experiments had proven that tumors wouldn't grow when the gene--and its protein product--were present. But "curing cancer" in the test tube is one thing. Now that they've found the gene stops cancer formation in an animal model, the next step would be to understand how the gene and its protein actually work.

Eventually, the scientists, led by Antonio Giordano, M.D., Ph.D., associate professor of pathology, anatomy and cell biology at Thomas Jefferson University in Philadelphia, would like to develop a gene therapy procedure against Rb2 to treat cancer.

Verifying Rb2's function, Dr. Giordano says, "shows the complexity of cancer.

"It's clear that Rb2 is one of a small number of tumor suppressor genes that play important roles in cancer," he says. "We know now that Rb2 can be therapeutically powerful. Understanding how they work is key to solving the puzzle of cancer formation. We think that Rb2 is used in combination with other tumor suppressor genes."

Dr. Giordano and his colleagues at Allegheny University of the Health Sciences and the University of Naples report their results October 7 in the Journal of the National Cancer Institute.

"The importance of this work is that it's the first time we have shown that the tumor suppressor, pRb2/p130, is able to suppress tumor growth in mice," says Dr. Giordano. "In the past, we only showed that Rb2 could suppress cancer cell lines from growing. Now we find it dramatically does so on mice. It's a very exciting study to show this dramatically inhibiting cancer cell growth."

While the biochemical pathway of tumor suppression isn't completely understood, "with this discovery, we have another tool," Dr. Giordano says. "It's known that Rb2 controls vital cell processes, including apoptosis (programmed cell death).

"Gene therapy would target cancers in which we know this gene is involved--lung, mesothelioma, endometrial, breast, glioblastoma, lymphoma," he says. "We are working on a delivery system for every cancer."


Story Source:

The above story is based on materials provided by Thomas Jefferson University. Note: Materials may be edited for content and length.


Cite This Page:

Thomas Jefferson University. "Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy." ScienceDaily. ScienceDaily, 7 October 1998. <www.sciencedaily.com/releases/1998/10/981007071833.htm>.
Thomas Jefferson University. (1998, October 7). Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/1998/10/981007071833.htm
Thomas Jefferson University. "Jefferson Scientists Suppress Tumor Growth In Animals, Aiming At Gene Therapy." ScienceDaily. www.sciencedaily.com/releases/1998/10/981007071833.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com
What HealthKit Bug Means For Your iOS Fitness Apps

What HealthKit Bug Means For Your iOS Fitness Apps

Newsy (Sep. 18, 2014) Apple has delayed the launch of the HealthKit app platform, citing a bug. Video provided by Newsy
Powered by NewsLook.com
U.S. Food Makers Surpass Calorie-Cutting Pledge

U.S. Food Makers Surpass Calorie-Cutting Pledge

Newsy (Sep. 18, 2014) Sixteen large food and beverage companies in the United States that committed to cut calories in their products far surpassed their target. Video provided by Newsy
Powered by NewsLook.com
Residents Vaccinated as Haiti Fights Cholera Epidemic

Residents Vaccinated as Haiti Fights Cholera Epidemic

AFP (Sep. 18, 2014) Haitians receive the second dose of the vaccine against cholera as part of the UN's vaccination campaign. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins